Infective endocarditis

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

ბოლო მიმოხილვა: 2 Dec 2025
ბოლო განახლება: 13 Nov 2025

შეჯამება

განსაზღვრება

ანამნეზი და გასინჯვა

ძირითადი დიაგნოსტიკური ფაქტორები

  • fever/chills
  • night sweats, malaise, fatigue, anorexia, weight loss, myalgias
  • weakness
  • arthralgias
  • headache
  • shortness of breath
  • meningeal signs
  • cardiac murmur
  • Janeway lesions
  • Osler nodes
  • Roth spots
სრული ტექსტი

სხვა დიაგნოსტიკური ფაქტორები

  • splinter hemorrhages
  • cutaneous infarcts
  • chest pain
  • back pain
  • palatal petechiae
სრული ტექსტი

რისკფაქტორები

  • prior history of infectious endocarditis
  • presence of artificial prosthetic heart valves
  • certain types of congenital heart disease
  • postheart transplant (patients who develop a cardiac valvulopathy)
  • immunocompromised state
  • presence of cardiac implanted electronic device or intravascular catheters (e.g., for hemodialysis)
  • acquired degenerative valve disease
  • mitral valve prolapse or bicuspid valve prolapse
  • hypertrophic cardiomyopathy
  • intravenous drug use
  • chronic Q fever
სრული ტექსტი

დიაგნოსტიკური კვლევები

1-ად შესაკვეთი გამოკვლევები

  • blood cultures
  • echocardiogram
  • CBC
  • CRP
  • serum chemistry panel with glucose
  • LFTs
  • urinalysis
  • ECG
სრული ტექსტი

გასათვალისწინებელი კვლევები

  • rheumatoid factor
  • erythrocyte sedimentation rate
  • complement levels
  • cardiac CT
  • MRI
  • nuclear imaging and PET
  • specific tests for blood culture-negative endocarditis
სრული ტექსტი

ახალი ტესტები

  • mean platelet volume (MPV)
  • anti‐beta-2‐glycoprotein I antibodies
  • D-dimer and troponin I
სრული ტექსტი

მკურნალობის ალგორითმი

საწყისი

suspected infective endocarditis

მწვავე

native valve: confirmed endocarditis

prosthetic valve: confirmed endocarditis

მიმდინარე

at high risk of infective endocarditis

კონტრიბუტორები

ექსპერტი მრჩევლები

Carl Zehner, MD

Assistant Professor of Medicine

University of Texas MD Anderson Cancer Center

Department of Cardiology

Houston

TX

გაფრთხილება:

CZ declares that he has no competing interests.

მადლიერება

Dr Carl Zehner would like to gratefully acknowledge Dr Ammara Mushtuq, Dr Tracey Keteepe-Arachi, Dr Aneil Malhotra, Dr Michael Papadakis, Professor Sanjay Sharma, Dr Jason C. Schultz, Dr Nisha K. Lassi, and Dr Nandan S. Anavekar, previous contributors to this topic.

გაფრთხილება:

TKA, MP, SS, JCS, NKL, and NSA declare that they have no competing interests. AMu declares that she is Principal Investigator on a grant from Merck on ceftolozane-tazobactam, writer for the Lancet family of journals, question writer for Blueprint Test preparations, and a peer-reviewer for Clinical Overviews, Elsevier (topics influenza and HIV). AMa is an author of a number of references cited in this topic.

რეცენზენტები

Vandana Desai, MD

Professor of Pediatrics

SMIMER Hospital

Gujarat

India

利益声明

VD declares that she has no competing interests.

Lucieni Oliveira Conterno, MD, PhD

Director

Clinical Epidemiology Unit

Marilia Medical School

Sao Paulo

Brazil

利益声明

LOC declares that she has no competing interests.

Andrew Wang, MD

Associate Professor of Medicine

Director, Cardiovascular Disease Fellowship Program

Duke University Medical Center

Durham

NC

利益声明

AW declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.全文  摘要

Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.全文  摘要

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.全文  摘要

Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18;143(20):e963-78.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Infective endocarditis images
  • 鉴别诊断

    • Rheumatic fever
    • Atrial myxoma
    • Libman-Sacks endocarditis
    更多 鉴别诊断
  • 指南

    • Blood culture-negative endocarditis
    • 2023 ESC guidelines for the management of endocarditis
    更多 指南
  • Videos

    Venepuncture and phlebotomy: animated demonstration

    How to perform an ECG: animated demonstration

    更多 操作视频
  • 患者教育信息

    Endocarditis

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明